Welcome to our dedicated page for OXLEY BRIDGE ACQ news (Ticker: OBAWU), a resource for investors and traders seeking the latest updates and insights on OXLEY BRIDGE ACQ stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OXLEY BRIDGE ACQ's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OXLEY BRIDGE ACQ's position in the market.
Oxley Bridge Acquisition Limited (NASDAQ: OBA) has announced the pricing of its $220 million initial public offering, consisting of 22 million units at $10.00 per unit. Each unit includes one Class A ordinary share and one-half redeemable warrant, with whole warrants exercisable at $11.50 per share.
Trading will commence on June 25, 2025 under symbol "OBAWU" on Nasdaq, with the shares and warrants later trading separately as "OBA" and "OBAWW". The company is a blank check company targeting global consumer and technology sectors with disruptive growth potential in Asia (excluding China, Hong Kong, and Macau).
The IPO, managed by Cantor Fitzgerald & Co., includes a 45-day over-allotment option for an additional 3.3 million units.
